InvestSMART

Bionomics Limited (ASX: BNO) - Announcements

DELISTED - Current share price for BNO : $0.010

ASX company news and announcements for Bionomics Limited (BNO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bionomics Limited (BNO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bionomics Limited (BNO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bionomics Limited (BNO)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- FDA Clears BNC210 Ph2 Social Anxiety Disorder IND (PREVAIL) 1 Nov 2021 10:02AM $0.125 $0.010 fallen by 92%
- 2021 Notice of AGM/Proxy Form 1 Nov 2021 10:00AM $0.125 $0.010 fallen by 92%
- Quarterly Activities/Appendix 4C Cash Flow Report 29 Oct 2021 5:30PM $0.125 $0.010 fallen by 92%
- Jobkeeper Payments Notification 29 Oct 2021 9:01AM $0.130 $0.010 fallen by 92.31%
- 2021 Corporate Governance Statement and Appendix 4G 29 Oct 2021 8:59AM $0.130 $0.010 fallen by 92.31%
- 2021 Annual Report 29 Oct 2021 8:54AM $0.130 $0.010 fallen by 92.31%
- Closing Date for Nomination of Director 14 Oct 2021 5:24PM $0.140 $0.010 fallen by 92.86%
- Notification of cessation of securities - BNO 7 Oct 2021 5:38PM $0.140 $0.010 fallen by 92.86%
- BNO prepares BNC210 for start of Phase 2 Acute SAD trial 20 Sep 2021 9:52AM $0.170 $0.010 fallen by 94.12%
- Cleansing Notice 2 Sep 2021 8:44AM $0.185 $0.010 fallen by 94.59%
- Application for quotation of securities - BNO 1 Sep 2021 9:49AM $0.185 $0.010 fallen by 94.59%
- Correction to Appendix 4E 31 Aug 2021 10:04AM $0.190 $0.010 fallen by 94.74%
- Full Year Statutory Accounts FY2021 25 Aug 2021 3:53PM $0.185 $0.010 fallen by 94.59%
- Preliminary Final Report FY2021 App 4E and Announcement 25 Aug 2021 3:48PM $0.185 $0.010 fallen by 94.59%
- BNO Announces Planned Capital Distribution to Shareholders 2 Aug 2021 9:00AM $0.150 $0.010 fallen by 93.33%
- BNO Announces Plans to Conduct U.S. Initial Public Offering 2 Aug 2021 8:57AM $0.150 $0.010 fallen by 93.33%
- Quarterly Activities and Cashflow Report 29 Jul 2021 8:57AM $0.155 $0.010 fallen by 93.55%
- Final Director's Interest Notice 19 Jul 2021 3:37PM $0.190 $0.010 fallen by 94.74%
- BNO Initiates Phase 2b ATTUNE Study of BNC210 in PTSD 6 Jul 2021 9:24AM $0.200 $0.010 fallen by 95%
- Initial Director's Interest Notice M. Davies 1 Jul 2021 2:33PM $0.190 $0.010 fallen by 94.74%
- Notification of cessation of securities - BNO 1 Jul 2021 9:02AM $0.190 $0.010 fallen by 94.74%
- Executive Chairman - New Employment Agreement 1 Jul 2021 9:01AM $0.190 $0.010 fallen by 94.74%
- Appointment and Resignation of Director 1 Jul 2021 9:01AM $0.190 $0.010 fallen by 94.74%
- Change of Telephone Number 18 Jun 2021 9:22AM $0.220 $0.010 fallen by 95.45%
- Change of Address 7 Jun 2021 4:21PM $0.185 $0.010 fallen by 94.59%

126 - 150 of 801 results

Page 6 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.